ChinaSecurities

Tianyin Pharmaceutical Co., Inc., founded in 1994, based in Chengdu, China, develops, manufactures, and sells 34 traditional Chinese medicines and other pharmaceutical products in China. Tianyin has a pipeline of 51 products, which are pending regulatory approvals with the China SFDA. 2Q09 revenue increased 30.4% to $10.1 million and net income increased 24.5% to $2.1 million. Gross margins improved to 51%. The company has $12.7 million in cash and equivalents.

We currently manufacture and market a comprehensive portfolio of 34 products of which 22 are listed in the highly selective National Medicine Catalog of the National Medical Insurance program. In addition, we have a pipeline of over 50 products pending regulatory approvals with a sizable upside market potential for continuous growth.